PlainRecalls
FDA Devices Moderate Class II Terminated

Xience Sierra TM Everolimus Eluting Coronary Stent System, RX 3.5mm x 33mmStrength: 100 ¿g/cm¿, Nominal Everolimus Content: 209 ¿g; Lot number 903224A,

Reported: June 24, 2020 Initiated: March 25, 2020 #Z-2370-2020

Product Description

Xience Sierra TM Everolimus Eluting Coronary Stent System, RX 3.5mm x 33mmStrength: 100 ¿g/cm¿, Nominal Everolimus Content: 209 ¿g; Lot number 903224A,

Reason for Recall

Incorrect expiration date

Details

Recalling Firm
Abbott Vascular
Units Affected
13 units
Distribution
US Nationwide distribution including in the states of NJ, HI, MD, FL, NV, CA, KS and PR. No foreign consignee
Location
Temecula, CA

Frequently Asked Questions

What product was recalled?
Xience Sierra TM Everolimus Eluting Coronary Stent System, RX 3.5mm x 33mmStrength: 100 ¿g/cm¿, Nominal Everolimus Content: 209 ¿g; Lot number 903224A,. Recalled by Abbott Vascular. Units affected: 13 units.
Why was this product recalled?
Incorrect expiration date
Which agency issued this recall?
This recall was issued by the FDA Devices on June 24, 2020. Severity: Moderate. Recall number: Z-2370-2020.